TABLE 3.
Diagnostic performance of the in-house-developed nsp8 and N gene RT-LAMP-CRISPR assays compared to the LightMix E gene RT-PCR assay for SARS-CoV-2 detection
| Molecular assay | Molecular assay result | LightMix E gene RT-PCR |
Sensitivity (%) | Kappa value (95% CI)a | P value by McNemar’s test | |
|---|---|---|---|---|---|---|
| Positive | Negative | |||||
| nsp8 RT-LAMP-CRISPR | ||||||
| Nasopharyngeal specimensb | Positive | 78 | 0 | 100 | 1 | 1 |
| Negative | 0 | 71 | ||||
| Saliva specimensc | Positive | 68 | 0 | 97.1 | 0.976 (0.942–1) | 0.5 |
| Negative | 2e | 100 | ||||
| All specimensd | Positive | 146 | 0 | 98.6 | 0.987 (0.97–1) | 0.5 |
| Negative | 2e | 171 | ||||
| N RT-LAMP-CRISPR | ||||||
| Nasopharyngeal specimensb | Positive | 78 | 0 | 100 | 1 | 1 |
| Negative | 0 | 71 | ||||
| Saliva specimensc | Positive | 68 | 0 | 97.1 | 0.976 (0.942–1) | 0.5 |
| Negative | 2e | 100 | ||||
| All specimensd | Positive | 146 | 0 | 98.6 | 0.987 (0.97–1) | 0.5 |
| Negative | 2e | 171 | ||||
CI, confidence interval.
Median Cp, 21.8 (range, 14.2 to 33.5).
Median Cp, 24.7 (range, 14.6 to 36.6).
Median Cp, 23.1 (range, 14.2 to 36.6).
The Cp values were 36.2 and 36.6.